Variables Associated With Survival in the Transplant and/or Nontransplant Cohort
| . | Transplant . | Nontransplant . | ||
|---|---|---|---|---|
| RR of Death . | P . | RR of Death . | P . | |
| Year diagnosis ≥88 | 0.58 | .003 | — | NS |
| Spleen size ≥10 cm | — | NS | 2.11 | <.001 |
| Female sex | 0.65 | .02 | 0.63 | .03 |
| Age >35 years | 1.41 | .04 | — | NS |
| . | Transplant . | Nontransplant . | ||
|---|---|---|---|---|
| RR of Death . | P . | RR of Death . | P . | |
| Year diagnosis ≥88 | 0.58 | .003 | — | NS |
| Spleen size ≥10 cm | — | NS | 2.11 | <.001 |
| Female sex | 0.65 | .02 | 0.63 | .03 |
| Age >35 years | 1.41 | .04 | — | NS |
Other variables considered: platelets at diagnosis (0 to 149, 150 to 699, ≥700 × 109/L, unknown), circulating blasts at diagnosis (0, 1 to 3, ≥4, unknown), WBC at diagnosis (<100, 100 to 199, ≥200 × 109/L).
Abbreviations: RR, relative risk; NS, not significant.